Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Chapman

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
European Journal of Clinical Investigation|June 1, 1996
Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemiaM Guérin, E Bruckert, P J Dolphin, et al.
European Journal of Biochemistry|November 1, 1981
Tryptic modification of human serum low-density lipoprotein leads to altered rates of turnover and intravascular transformation in the guinea pigP K Weech, M J Chapman, G L Mills, et al.
Journal of Lipid Research|June 1, 1987
Lipoprotein composition of human suction-blister interstitial fluidB Vessby, S Gustafson, M J Chapman, et al.
Journal of Lipid Research|September 1, 1983
Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculusM C Camus, M J Chapman, P Forgez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidationP Lesnik, C Dentan, A Vonica, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1990
Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetateM Rouis, F Nigon, C Lafuma, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Core lipid structure is a major determinant of the oxidative resistance of low density lipoproteinB Schuster, R Prassl, F Nigon, et al.
Atherosclerosis|November 1, 1995
Non-enzymatic glycation of lipoprotein(a) in vitro and in vivoC Doucet, T Huby, J Ruiz, et al.
Journal of Lipid Research|December 1, 1983
Spur cells in patients with alcoholic liver cirrhosis are associated with reduced plasma levels of apoA-II, HDL3, and LDLG Duhamel, P Forgez, B Nalpas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDLL Petit, P Lesnik, C Dachet, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
European Journal of Clinical Investigation|June 1, 1996
Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemiaM Guérin, E Bruckert, P J Dolphin, et al.
European Journal of Biochemistry|November 1, 1981
Tryptic modification of human serum low-density lipoprotein leads to altered rates of turnover and intravascular transformation in the guinea pigP K Weech, M J Chapman, G L Mills, et al.
Journal of Lipid Research|June 1, 1987
Lipoprotein composition of human suction-blister interstitial fluidB Vessby, S Gustafson, M J Chapman, et al.
Journal of Lipid Research|September 1, 1983
Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculusM C Camus, M J Chapman, P Forgez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidationP Lesnik, C Dentan, A Vonica, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1990
Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetateM Rouis, F Nigon, C Lafuma, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Core lipid structure is a major determinant of the oxidative resistance of low density lipoproteinB Schuster, R Prassl, F Nigon, et al.
Atherosclerosis|November 1, 1995
Non-enzymatic glycation of lipoprotein(a) in vitro and in vivoC Doucet, T Huby, J Ruiz, et al.
Journal of Lipid Research|December 1, 1983
Spur cells in patients with alcoholic liver cirrhosis are associated with reduced plasma levels of apoA-II, HDL3, and LDLG Duhamel, P Forgez, B Nalpas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDLL Petit, P Lesnik, C Dachet, et al.
Pageof 21